Plastic and Reconstructive Surgery, Global Open (Jul 2022)

Safety and Efficacy of Transform for Noninvasive Lipolysis and Circumference Reduction of the Abdomen

  • Matthew Novak, MD,
  • David Weir, NP-C,
  • Rod J. Rohrich, MD

DOI
https://doi.org/10.1097/GOX.0000000000004446
Journal volume & issue
Vol. 10, no. 7
p. e4446

Abstract

Read online

Summary:. Noninvasive body contouring has seen a precipitous rise in popularity since its advent in the early 2000s. With this rise in popularity, there has been an expansion in the types and number of noninvasive devices for muscle hypertrophy and fat lipolysis. The Transform radiofrequency and electrical muscle stimulation device is a newly introduced device for noninvasive abdominal body contouring. The present study is a prospective clinical trial evaluating the efficacy of the Transform device on abdominal circumference. Fifteen patients were enrolled and received three treatment sessions with the Transform device. On average, patients saw changes in abdominal circumference (−0.43 cm, P = 0.48), caliper pinch thickness (−6.07 mm, P = 0.0036), and ultrasound fat thickness (−5.40 mm, P < 0.001) at 3 months posttreatment with minimal discomfort and high patient satisfaction. Ultimately, this study demonstrates that the Transform device is a safe and effective noninvasive option for fat lipolysis and muscular hypertrophy.